20k doses of Covaxin reach Bengaluru, to be used alongside Covishield

The state had already received 8 lakh doses of Covishield from the Pune-based Serum Institute of India since Tuesday.
covaxin
covaxin
Written by:

The first batch of Covaxin from Hyderabad-based Bharat Biotech of 20,000 doses meant for healthcare workers and other frontline workers, as part of the first phase of vaccination, arrived in Bengaluru on Thursday morning as scheduled. The state had already received 8 lakh doses of Covishield from the Pune-based Serum Institute of India since Tuesday.

"The state will soon receive 20,000 doses of Covaxin from Hyderabad by air and these will be used to inoculate 16 lakh frontline warriors across the state in phase one from January 16 onwards," Karnataka Health Minister Dr Sudhakar K had said earlier in a statement.

"Covaxin has 5ml vaccine in a vial as against 10ml vaccine in Covishield vial. We can vaccine 20 people with one vial on average," he added.

The second consignment of 1.5 lakh doses of Covishield reached Belagavi from Pune by road in refrigerated vehicles.

The Serum Institute sent 6.5 lakh doses of its vaccine by air cargo to Bengaluru on Tuesday for distribution in 8 districts in the region.

"The doses are packed in 14,700 bottles, with each bottle having 10 units (ml). The vaccine will be administered twice with a 28 day gap between first and second dose," said a state health official.

The vaccines have been stored in cold chambers at 3 degree Celsius temperature.

About 36,000 doses have been allotted for frontline warriors in Belagavi district.

The department has trained about 28,000 health workers to inject the vaccine at 180 centres in the state's northwest region spanning Bagalkot, Dharwad, Gadag, Haveri, Koppal, Uttara Kannada and Vijayapura districts.

The vaccine will be administered at 235 sites across the state, and cold chains have been set up to store them in all the 30 districts. Task forces have been formed to supervise the exercise.

The state will get 13.90 lakh doses of vaccine in the first phase.

Related Stories

No stories found.
The News Minute
www.thenewsminute.com